JCR Pharmaceuticals Co., Ltd. (4552) Stock Statistics & Valuation Metrics

JCR Pharmaceuticals Co., Ltd. has a market cap or net worth of JPY 62.37B. The enterprise value is JPY 115.01B.

Market Cap

JPY 62.37B

Enterprise Value

JPY 115.01B

JCR Pharmaceuticals Co., Ltd. has 129,686,310 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

129,686,310

Owned by Insiders

―

Owned by Institutions

4.11%

JCR Pharmaceuticals Co., Ltd.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 0.29%.

Return on Equity (ROE)

0.05

Return on Assets (ROA)

0.02

Return on Invested Capital (ROIC)

0.29%

Return on Capital Employed (ROCE)

0.01

Revenue Per Employee

40.93M

Profits Per Employee

2.21M

Employee Count

985

Asset Turnover

0.37

Inventory Turnover

0.43

The current PE Ratio of JCR Pharmaceuticals Co., Ltd. is -17.61. JCR Pharmaceuticals Co., Ltd.’s PEG ratio is 0.03.

PE Ratio

-17.61

PS Ratio

1.54

PB Ratio

1.46

Price to FCF

-10.31

Price to Operating Cash Flow

-31.49

PEG Ratio

0.03

In the last 12 months, JCR Pharmaceuticals Co., Ltd. had revenue of 40.32B and earned 2.18B in profits. Earnings per share was 17.86.

Revenue

40.32B

Gross Profit

30.06B

Operating Income

431.00M

Pretax Income

3.22B

Net Income

2.18B

EBITDA

6.18B

Earnings Per Share (EPS)

17.86

In the last 12 months, operating cash flow was -1.90B and capital expenditures -3.90B, giving a free cash flow of -5.80B billion.

Operating Cash Flow

-1.90B

Free Cash Flow

-5.80B

Free Cash Flow per Share

-47.47

JCR Pharmaceuticals Co., Ltd. pays an annual dividend of JPY 10.00, resulting in a dividend yield of 4.06%

Dividend Per Share

JPY 10.00

Dividend Yield

4.06%

Payout Ratio

-105.99%

Free Cash Flow Yield

-9.64%

Earnings Yield

-5.64%

Beta

0.95

52-Week Price Change

-18.51%

50-Day Moving Average

512.15

200-Day Moving Average

527.54

Relative Strength Index (RSI)

44.69

Average Volume (3m)

825.58K

JCR Pharmaceuticals Co., Ltd. upcoming earnings date is Jan 28, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 29, 2026

Next Earnings Date

Jan 28, 2027

Ex-Dividend Date

Mar 30, 2026

JCR Pharmaceuticals Co., Ltd. as a current ratio of 1.16, with Debt / Equity ratio of 114.81%

Current Ratio

1.16

Quick Ratio

0.67

Debt to Market Cap

0.78

Net Debt to EBITDA

6.45

Interest Coverage Ratio

1.08

In the past 12 months, JCR Pharmaceuticals Co., Ltd. has paid 1.02B in taxes.

Income Tax

1.02B

Effective Tax Rate

0.32

JCR Pharmaceuticals Co., Ltd. EV to EBITDA ratio is -282.73, with an EV/FCF ratio of -19.54.

EV to Sales

2.91

EV to EBITDA

-282.73

EV to Free Cash Flow

-19.54

EV to Operating Cash Flow

-59.61

JCR Pharmaceuticals Co., Ltd. has JPY 10.44B in cash and marketable securities with JPY 63.66B in debt, giving a net cash position of -JPY 53.22B billion.

Cash & Marketable Securities

JPY 10.44B

Total Debt

JPY 63.66B

Net Cash

-JPY 53.22B

Net Cash Per Share

-JPY 410.38

Tangible Book Value Per Share

JPY 319.81

Gross margin is 70.18%, with operating margin of -13.81%, and net profit margin of -8.73%.

Gross Margin

70.18%

Operating Margin

-13.81%

Pretax Margin

-8.03%

Net Profit Margin

-8.73%

EBITDA Margin

-1.03%

EBIT Margin

-6.63%

The average price target for JCR Pharmaceuticals Co., Ltd. is JPY 766.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

JPY 766.67

Price Target Upside

55.51% Upside

Analyst Consensus

Moderate Buy

Analyst Count

3

Revenue Growth Forecast

3.05%

EPS Growth Forecast

-67.53%

Smart Score

―

AI Score

52